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doi:10.1016/j.jtcvs.2006.10.018he concept of cardiologists implanting percutaneous aortic valves in an
angiography suite evokes multiple reactions from cardiac surgeons. Rarely
are these reactions particularly favorable. The opinions of cardiac surgeons
egarding the development and the potential abuse of these percutaneous technol-
gies sound familiar because similar opinions were expressed in response to the
evelopment of percutaneous coronary technologies a quarter of a century ago.
The concerns regarding percutaneous aortic valves include “we have a great
peration now,” “few patients are inoperable,” “the percutaneous devices have
roblems,” “it will be dangerous because these devices will be misused,” and
patients will not get true informed consent.” All these arguments and concerns have
ome truth to them, but none will define the future of percutaneous aortic valve
echnologies, just as similar concerns have failed to define the anatomic treatment
f coronary artery disease.
Percutaneous aortic valve devices are here to stay. First, although conventional
ortic valve replacement is a safe operation in experienced hands, it is not perfectly
afe and there are patients with combinations of problems including multiple
revious operations, radiation heart disease, liver failure, kidney failure, and diffuse
therosclerosis for whom the risk of conventional aortic valve replacement is more
han trivial. Second, today’s percutaneous devices are primitive, but progress is
ikely to be rapid. Percutaneous coronary interventions have been, and still are,
imited by fundamental biologic processes, including the cellular and tissue re-
ponse to injury (restenosis) and the complexities of the coagulation system. The
ngineering aspects of percutaneous coronary interventions have been successful.
o far no such fundamental problems appear to limit percutaneous aortic valve
echnologies any more than they limit conventional aortic valve technologies.
mproving the percutaneous aortic valve devices appears to be pretty much a matter
f engineering, making their deficiencies more amenable to solution than the
roblems of restenosis have been.
We should have learned from the coronary experience that many patients have a
trong attraction to percutaneous rather than open surgical procedures, and unless
he procedure-related risks of percutaneous procedures are substantially greater than
he procedure-related risks of open procedures, many patients will select the
ess-invasive strategy even if the long-term outcomes are inferior and even if they
eceive accurate informed consent.
A further lesson we should have learned from the coronary experience is that
xpressing concern about technologies that we are not capable of using is relatively
neffective. For cardiac surgeons to have an impact on the use of percutaneous aortic
alve technology and to be able to assure ourselves that patients have received
nformed consent and that these devices are not misused, we must be able to use
hese technologies ourselves. In this setting, cardiac surgeons will be able to render
trong opinions with a diminished procedure-related bias.
Catheter-based valve procedures are surgery, just a different kind of surgery. For
ardiac surgeons to gain expertise with multiple types of valve procedures will be
tortuous journey, but the journey must start today.
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